Status:
COMPLETED
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Lead Sponsor:
University of Utah
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
Up to 3 years
Brief Summary
This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008....
Detailed Description
This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008....
Eligibility Criteria
Inclusion
- birth weight less than 1200 gm
Exclusion
- none
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00795990
Start Date
November 1 2008
End Date
November 1 2014
Last Update
December 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108